Esperion Therapeutics, Inc.: accounts_payable
| Value | {"amount": 34864000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-09-30) |
| Status | current |
| Entity | Esperion Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:06:45.971287+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fb5d8638-24bd-465a-9983-436da6602f29
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-24-046307Retrieved: 2026-08-19T14:06:45.971287+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001434868/accounts-payable/2024-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fb5d8638-24bd-465a-9983-436da6602f29
History
- no predecessors — first report